2 years ago

Genomes.io Secures $20 Million Investment from GEM Digital

  • Genomes.io, a London-based biotech company focusing on the safe and private monetization of genomic data, has received a $20 million commitment from GEM Digital Limited

  • The funding will be used to accelerate the company's technological growth

  • Genomes.io, founded in 2018 by Aldo de Pape, provides a secure DNA data storage and sharing application, enabling users to sequence, store, and commercialize their genomic data

  • The company has been developing its infrastructure with partners like AMD and ConsenSys to ensure safe and secure data management

  • Genomes.io won the Deloitte Tech Fast 50 Challenge Award in 2022 for its innovative Web3 technology in healthcare.

      • ProblemHealthcare

      "Sharing DNA data for research is currently difficult, risky, and often exploitative. Individuals don't have control over their data, and companies can misuse it for profit."

      Solution

      "Genomes.io is building a secure platform that allows individuals to control their DNA data and get paid for sharing it with researchers and companies in a fair and transparent way. This enables faster and better scientific discoveries while respecting individual privacy and ownership."

      Covered on